1. Home
  2. HUMA vs RAAQ Comparison

HUMA vs RAAQ Comparison

Compare HUMA & RAAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.35

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

RAAQ

Real Asset Acquisition Corp. Class A Ordinary Share

HOLD

Current Price

$11.11

Market Cap

269.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUMA
RAAQ
Founded
2004
2024
Country
United States
United States
Employees
184
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.6M
269.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HUMA
RAAQ
Price
$1.35
$11.11
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$6.19
N/A
AVG Volume (30 Days)
7.8M
277.3K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$444.16
N/A
Revenue Next Year
$248.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$9.62
52 Week High
$2.84
$12.10

Technical Indicators

Market Signals
Indicator
HUMA
RAAQ
Relative Strength Index (RSI) 62.33 45.68
Support Level $0.89 $10.30
Resistance Level $1.72 $11.97
Average True Range (ATR) 0.13 0.44
MACD 0.03 -0.04
Stochastic Oscillator 75.52 19.12

Price Performance

Historical Comparison
HUMA
RAAQ

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About RAAQ Real Asset Acquisition Corp. Class A Ordinary Share

Real Asset Acquisition Corp is a blank check company.

Share on Social Networks: